|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen J, Fu Z, Ji C, Gu P, Xu P, Yu N, Kan
Y, Wu X, Shen R and Shen Y: Systematic gene microarray analysis of
the lncRNA expression profiles in human uterine cervix carcinoma.
Biomed Pharmacother. 72:83–90. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sakuragi N: Refining insight into cervical
cancer progression. Lancet Oncol. 15:371–372. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Schiffman M, Wentzensen N, Wacholder S,
Kinney W, Gage JC and Castle PE: Human papillomavirus testing in
the prevention of cervical cancer. J Natl Cancer Inst. 103:368–383.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Baak JP, Kruse AJ, Robboy SJ, Janssen EA,
van Diermen B and Skaland I: Dynamic behavioural interpretation of
cervical intraepithelial neoplasia with molecular biomarkers. J
Clin Pathol. 59:1017–1028. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lee M, Kim HJ, Kim SW, Park SA, Chun KH,
Cho NH, Song YS and Kim YT: The long non-coding RNA HOTAIR
increases tumour growth and invasion in cervical cancer by
targeting the Notch pathway. Oncotarget. 7:44558–44571. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mattick JS: The genetic signatures of
noncoding RNAs. PLoS Genet. 5:e10004592009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gibb EA, Brown CJ and Lam WL: The
functional role of long non-coding RNA in human carcinomas. Mol
Cancer. 10:382011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mercer TR, Dinger ME and Mattick JS: Long
non-coding RNAs: Insights into functions. Nat Rev Genet.
10:155–159. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Calore F, Lovat F and Garofalo M:
Non-coding RNAs and cancer. Int J Mol Sci. 14:17085–17110. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang J, Liu SC, Luo XH, Tao GX, Guan M,
Yuan H and Hu DK: Exosomal long noncoding RNAs are differentially
expressed in the cervicovaginal lavage samples of cervical cancer
patients. J Clin Lab Anal. 30:1116–1121. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gibb EA, Becker-Santos DD, Enfield KS,
Guillaud M, Niekerk Dv, Matisic JP, Macaulay CE and Lam WL:
Aberrant expression of long noncoding RNAs in cervical
intraepithelial neoplasia. Int J Gynecol Cancer. 22:1557–1563.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jen J, Tang YA, Lu YH, Lin CC, Lai WW and
Wang YC: Oct4 transcriptionally regulates the expression of long
non-coding RNAs NEAT1 and MALAT1 to promote lung cancer
progression. Mol Cancer. 16:1042017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen X, Kong J, Ma Z, Gao S and Feng X: Up
regulation of the long non-coding RNA NEAT1 promotes esophageal
squamous cell carcinoma cell progression and correlates with poor
prognosis. Am J Cancer Res. 5:2808–2815. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Peng W, Wang Z and Fan H: LncRNA NEAT1
impacts cell proliferation and apoptosis of colorectal cancer via
regulation of akt signaling. Pathol Oncol Res. 23:651–656. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mang Y, Li L, Ran J, Zhang S, Liu J, Li L,
Chen Y, Liu J, Gao Y and Ren G: Long noncoding RNA NEAT1 promotes
cell proliferation and invasion by regulating hnRNP A2 expression
in hepatocellular carcinoma cells. Onco Targets Ther. 10:1003–1016.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ergun S and Oztuzcu S: Oncocers:
ceRNA-mediated cross-talk by sponging miRNAs in oncogenic pathways.
Tumour Biol. 36:3129–3136. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Clemson CM, Hutchinson JN, Sara SA,
Ensminger AW, Fox AH, Chess A and Lawrence JB: An architectural
role for a nuclear noncoding RNA: NEAT1 RNA is essential for the
structure of paraspeckles. Mol Cell. 33:717–726. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sasaki YT, Ideue T, Sano M, Mituyama T and
Hirose T: MENepsilon/beta noncoding RNAs are essential for
structural integrity of nuclear paraspeckles. Proc Natl Acad Sci
USA. 106:pp. 2525–2530. 2009; View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen ZJ, Zhang Z, Xie BB and Zhang HY:
Clinical significance of up-regulated lncRNA NEAT1 in prognosis of
ovarian cancer. Eur Rev Med Pharmacol Sci. 20:3373–3377.
2016.PubMed/NCBI
|
|
21
|
Chakravarty D, Sboner A, Nair SS,
Giannopoulou E, Li R, Hennig S, Mosquera JM, Pauwels J, Park K,
Kossai M, et al: The oestrogen receptor alpha-regulated lncRNA
NEAT1 is a critical modulator of prostate cancer. Nat Commun.
5:53832014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fang J, Li Y, Zhang J, Yan M, Li J, Bao S
and Jin T: Correlation between polymorphisms in microRNA-regulated
genes and cervical cancer susceptibility in a Xinjiang Uygur
population. Oncotarget. 8:31758–31764. 2017.PubMed/NCBI
|
|
23
|
Qian K, Liu G, Tang Z, Hu Y, Fang Y, Chen
Z and Xu X: The long non-coding RNA NEAT1 interacted with miR-101
modulates breast cancer growth by targeting EZH2. Arch Biochem
Biophys. 615:1–9. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li JH, Zhang SQ, Qiu XG, Zhang SJ, Zheng
SH and Zhang DH: Long non-coding RNA NEAT1 promotes malignant
progression of thyroid carcinoma by regulating miRNA-214. Int J
Oncol. 50:708–716. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Huang B, Liu C, Wu Q, Zhang J, Min Q,
Sheng T, Wang X and Zou Y: Long non-coding RNA NEAT1 facilitates
pancreatic cancer progression through negative modulation of
miR-506-3p. Biochem Biophys Res Commun. 482:828–834. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jiang R, Zhang C, Liu G, Gu R and Wu H:
MicroRNA-101 inhibits proliferation, migration and invasion in
osteosarcoma cells by targeting ROCK1. Am J Cancer Res. 7:88–97.
2017.PubMed/NCBI
|
|
27
|
Wang L, Yao J, Sun H, He K, Tong D, Song T
and Huang C: MicroRNA-101 suppresses progression of lung cancer
through the PTEN/AKT signaling pathway by targeting DNA
methyltransferase 3A. Oncol Lett. 13:329–338. 2017.PubMed/NCBI
|
|
28
|
Liu J, Pang Y, Wang H, Li Y, Sun X, Xu F,
Ren H and Liu D: miR-101 inhibits the proliferation and migration
of breast cancer cells via downregulating the expression of DNA
methyltransferase 3a. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi.
32:299–303. 2016.(In Chinese). PubMed/NCBI
|
|
29
|
Zheng HB, Zheng XG and Liu BP: miRNA-101
inhibits ovarian cancer cells proliferation and invasion by
down-regulating expression of SOCS-2. Int J Clin Exp Med.
8:20263–20270. 2015.PubMed/NCBI
|
|
30
|
Huang F, Lin C, Shi YH and Kuerban G:
MicroRNA-101 inhibits cell proliferation, invasion and promotes
apoptosis by regulating cyclooxygenase-2 in Hela cervical carcinoma
cells. Asian Pac J Cancer Prev. 14:5915–5920. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liang X, Liu Y, Zeng L, Yu C, Hu Z, Zhou Q
and Yang Z: miR-101 inhibits the G1-to-S phase transition of
cervical cancer cells by targeting Fos. Int J Gynecol Cancer.
24:1165–1172. 2014. View Article : Google Scholar : PubMed/NCBI
|
